CTRI/2023/01/048971尚未招募2 期
Comparative Clinical Evaluation of Unani Formulation in redesigned gel form with its classical Bukhoor form in the Management of Knee Osteoarthritis.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of Knee OA according to American College of Rheumatology (ACR) criteria
- •Clinical classification criteria plus radiographic findings (X-ray) for knee osteoarthritis.
- •1.Pain in for most days of the prior month and â??oneâ?? of the following three
- •ï?¼ Morning stiffness <=30 minutes duration.
- •ï?¼ Age 40 to 65 years.
- •ï?¼ Crepitus on active knee movement
- •2.Presence of Osteophytes on knee Radiograph.
- •Patients with pain intensity score of 3 cm or
- •more on a 10 cm visual analog scale (VAS).
- •Willingness and ability to accept intervention and to comply with the requirements of the protocol.
排除标准
- •Ã? Pregnant and lactating females.
- •Ã? Severely ill patients.
- •Ã? History of significant trauma, infection or
- •presence of hematoma at the site of knee and/or
- •knee surgery.
- •Ã? History of other musculoskeletal disorders.
- •Ã? Known case of malignancy.
- •Ã? Patients taking NSAIDâ??s and corticosteroids, (a
- •wash out period of 1week and 4 weeks
- •respectively is required before enrolling
- •Ã? Unwilling to participate in the study.
研究者
相似试验
尚未招募
2 期
Effect of Unani Formualtions in QoobaCTRI/2024/04/065285Department Amraze jild wa zohrawiya Ajaml khan tibbiya college Aligarh Muslim University ALIGARH
尚未招募
2 期
Comparative Clinical Study of Unani Formulations in the Management of Abnormal Vaginal DischargeCTRI/2024/08/072386State Takmeel Uttib College And Hospital
进行中（未招募）
2 期
Evaluation of efficacy and safety of Unani formulation in AcneCTRI/2017/07/009004Dept of Moalajat Jamia Hamdard
尚未招募
2 期
Effect of Unani formulation (Joshanda) on Iltihab Tajawif al-Anf Muzmin (Chronic Sinusitis)CTRI/2020/05/025388Central council for Research in Unani Medicine New Delhi
尚未招募
2 期
To see the effect of Unani formulation as an add-on therapy along with Allopathic treatment in the Covid-19 patientsCTRI/2021/04/032647Ministry of AYUSH